Captopril is a sulfhydryl ACE inhibitor initially used in the treatment of hypertension and heart failure, and is protective against retinopathy and nephropathy (Parving et al. 1988; UK Prospective Diabetes Study Group 1998). This evidence concerns the gene ACE and retinal disorder.